L’IRIC présente la 41e édition de son programme des conférences scientifiques – Automne 2026.
Soyez des nôtres pour entendre des chercheurs et des chercheuses d’élite de renom en provenance du Canada, des États-Unis et de l’Europe présenter leurs percées scientifiques les plus récentes.
Notez que les conférences auront lieu en présentiel, les lundis de 11 h 30 à 12 h 30, à la salle Salle S1-151 Pavillon Jean-Coutu, 2950 chemin de Polytechnique.
11 h 30 à 12 h 30
Conférences en anglais
Entrée libre
14 SEPT
Cédric Tremblay | University of Manitoba, Winnipeg, MB, CA
Beyond Therapy Resistance: Cracking the Blueprint of Leukemia Relapse
Beyond Therapy Resistance: Cracking the Blueprint of Leukemia Relapse
21 SEPT
Ivan Topisirovic | McGill University, Montréal, QC, CA
Translational Rheostat Drives Breast Cancer Metastasis
Translational Rheostat Drives Breast Cancer Metastasis
12 SEPT
Nagarajan Vaidehi | Beckman Research Institute, Duarte-Los Angeles, CA, US
Interpretable AI For Uncovering Cooperativity and Allostery in Proteins
Interpretable AI For Uncovering Cooperativity and Allostery in Proteins
5 OCT
Michel Salzet | Université de Lille, FR
Ghost in the Cell and Therapies in Cancer
Ghost in the Cell and Therapies in Cancer
19 OCT
Jakob Nilsson | Danish Cancer Institute, Copenhague, DK
Regulation and Substrate Specificity of PP2A-like Protein Phosphatases
Regulation and Substrate Specificity of PP2A-like Protein Phosphatases
26 OCT
Miriam Carolin Stoeber | Université de Genève, Genève, CH
Probing and Modulating GPCR Function with Subcellular Resolution
Probing and Modulating GPCR Function with Subcellular Resolution
2 NOV
Mélanie Laurin | Université Laval, Québec, QC, CA
From Cells to Patterns: How Rho GTPases Shape Skin Organization During Embryonic Development
From Cells to Patterns: How Rho GTPases Shape Skin Organization During Embryonic Development
9 NOV
Sylvie Mader | IRIC, Université de Montréal, Montréal, QC, CA
Understanding the Mechanisms of Action of Cancer Therapeutic Agents to Improve Patient Outcomes
Understanding the Mechanisms of Action of Cancer Therapeutic Agents to Improve Patient Outcomes
16 NOV
Norman Iscove | University of Toronto, Toronto, ON, CA
Self-Renewal as a Master Vulnerability Spanning Diverse Myeloproliferative/leukemic Disorders
Self-Renewal as a Master Vulnerability Spanning Diverse Myeloproliferative/leukemic Disorders
23 NOV
Yoshiaki Tanaka | HMR – Université de Montréal, Montréal, QC, CA
Application of Brain Tumor Organoid for Drug Testing
Application of Brain Tumor Organoid for Drug Testing
30 NOV
Yoshiaki Tanaka | HMR – Université de Montréal, Montréal, QC, CA
Application of Brain Tumor Organoid for Drug Testing
Application of Brain Tumor Organoid for Drug Testing
7 DEC
Simon Gaudreau | Immune Biosolutions, Université de Sherbrooke, Sherbrooke, QC, CA
To be announced
To be announced
DEC 14
Gerardo Ferbeyre | Université de Montréal, Montréal, QC, CA
Chromatin Opening Drives Commitment to Senescence
Chromatin Opening Drives Commitment to Senescence